Targeted Hyperthermia - Preparation for pre-clinical studies started in 2009 with the Australian National University in Canberra, the University of Sydney and other institutions.
Hollow Microspheres - Sirtex has exclusive worldwide rights to hollow, biodegradable microsphere technology developed by the University of New South Wales (UNSW).